EKF Diagnostics Holdings plc (EKF) Ordinary 1p

Sell:25.90pBuy:27.90p1.15p (4.25%)

Prices delayed by at least 15 minutes
Sell:25.90p
Buy:27.90p
Change:1.15p (4.25%)
Prices delayed by at least 15 minutes
Sell:25.90p
Buy:27.90p
Change:1.15p (4.25%)
Prices delayed by at least 15 minutes

Company Information

About this company

EKF Diagnostics Holdings plc is a diagnostics and biotechnology company specializing in the manufacturing and distribution of advanced medical technologies and patient-focused solutions. The Company develops and produces in-vitro diagnostic (IVD) devices and tests designed for use at or near the patient’s location. It provides a suite of products for diabetes management, including glucose monitoring systems and associated consumables. It offers devices, supplies, and consumables for measuring hemoglobin levels, including tools for detecting hemoglobin variants. It also develops and supplies diagnostic and therapeutic enzymes, proteins, reagents, and biomaterials. It provides precision fermentation, custom bioprocessing, and contract manufacturing services for pharmaceuticals and other biological products. It supplies beta-hydroxybutyrate (HB) products used in ketone detection to support the diagnosis of diabetic ketoacidosis and other clinical conditions.

Key people

Julian Huw Baines
Executive Chairman of the Board
Gavin Joseph Jones
Chief Executive Officer, Executive Director
Stephen Young
Chief Financial Officer, Executive Director
Christopher Harwood Bernard Mills
Non-Executive Director
Christian Alexander Rigg
Senior Independent Non-Executive Director
Jennifer Ann Julia Winter
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    EKF
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    GB0031509804
  • Market cap
    £116.32m
  • Employees
    303
  • Shares in issue
    450.29m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.